Patients typically notice reduced panic frequency within the first month, with complete symptom resolution by 3 months when B12 deficiency was the primary cause
Lenmeldy is the first FDA-approved gene therapy for MLD, which is caused by a deficiency of the arylsulfatase A (ARSA) enzyme, a state that leads to a buildup of fatty substances in the cells
Vitamin b12 stores in the liver typically last 3 to 5 years
Indias pharma sector eyes GLP-1 opportunity Indian pharmaceutical manufacturers, renowned for their generics expertise, are positioning themselves to play a pivotal role in the GLP-1 markets expansion
Most nausea and vomiting occur during dose increases rather than at stable doses
For those residents in Oswego, New York, eager for this treatment, staying informed about developments related to Retatrutide FDA approval is essential